Mercalis and PharmaCord Merge and Rebrand as Valeris

Permira Makes Substantial Growth Investment in PharmaCord

June 6, 2024

Healthcare Services

Permira (via a company backed by Permira funds) has signed a definitive agreement to make a substantial growth investment in PharmaCord, a Jeffersonville, Indiana-based tech-enabled patient services provider for specialty pharmaceuticals. Founder and CEO Nitin Sahney and the management team will remain significant investors and operators; terms were not disclosed and the deal is expected to close by Q4 2024.

Altaris Combines Kindeva Drug Delivery and Meridian Medical Technologies

December 13, 2022

Medical Devices

Altaris has completed the combination of its portfolio companies Kindeva Drug Delivery and Meridian Medical Technologies into a single, global drug‑device CDMO that will operate under the Kindeva name. The combined company expands capabilities across parenteral, inhalation, transdermal and intradermal delivery formats; Milton Boyer (formerly Meridian CEO) will lead the combined business.

Mercalis (formerly TrialCard) Acquires Triangle Insights Group

April 12, 2022

Healthcare Services

Mercalis (formerly TrialCard) acquired Triangle Insights Group, a Durham-based life sciences strategy consulting firm, to expand its commercialization capabilities. The transaction is an add-on to the Mercalis platform (which is backed by Odyssey Investment Partners) and will retain all TIG partners and employees as Mercalis integrates strategic insights, pricing and market access expertise into its full-service commercialization offering.

MedPharm and Tergus Pharma Merge to Create Topical & Transdermal CDMO Leader

July 8, 2024

Pharmaceuticals

MedPharm and Tergus Pharma have merged and will operate under the MedPharm name to create an integrated, end-to-end topical and transdermal CDMO. Ampersand Capital Partners and Bourne Partners Strategic Capital assume majority ownership of the combined company while Great Point Partners retains a significant minority stake; Michael Kane is appointed CEO and Patrick Walsh remains Executive Chairman.

Altaris Capital Partners Acquires Meridian Medical Technologies from Pfizer

December 30, 2021

Medical Devices

Altaris Capital Partners has entered into an agreement to acquire Meridian Medical Technologies from Pfizer. Meridian, a pioneer in emergency response drug-device combination products and auto-injectors with facilities in St. Louis, Missouri and Columbia, Maryland and more than 750 employees, will become an Altaris portfolio company to expand the firm's capabilities in medical countermeasures and emergency response solutions.

Argus Media Acquires Mercaris

June 27, 2023

Data & Analytics

Argus Media has acquired Mercaris, a US provider of sustainable agriculture price assessments, analytics and forecasts for organic and non-GMO commodities. The deal (terms undisclosed) will expand Argus's agriculture pricing and analytics capabilities in the Americas and accelerate product development into related markets such as biofuels and agricultural inputs.